Status:
COMPLETED
HIV Pre-exposure Prophylaxis Implementation Hong Kong Study
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Brief Summary
While pre-exposure prophylaxis (PrEP) is widely recommended and a number of pilot studies are on-going worldwide, progress of its implementation in the real world setting has been slow, especially in ...
Eligibility Criteria
Inclusion
- Can communicate in written and spoken English or Chinese
- Is normally resident in Hong Kong
- Has tested HIV antibody negative in the past 3 months
- Has more than 1 episode of unprotected sex (especially anal sex) in the preceding 6 months
- Has any one of the following experiences in the past 6 months: chemsex engagement, group sex, multiple sex partners, STI diagnosis, having sex partner(s) with HIV+ve status
- Is inclined to engage in high risk sexual activities
Exclusion
- Chronic HBV infection (HBsAg +ve)
- Impaired renal function, defined as estimated glomerular filtration rate (eGFR) \< 60mL/min/1.73m2
- Having any form of mental illnesses
- Inability or refusal to give consent
- Prisoners or any institutionalised persons
- Pregnant or planning to get pregnant (for female)
- Injection drug user
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2024
Estimated Enrollment :
339 Patients enrolled
Trial Details
Trial ID
NCT04367688
Start Date
March 1 2020
End Date
January 31 2024
Last Update
February 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hospital
Hong Kong, Hong Kong